[Results of surgical therapy in esophagus and XXXX ].

@entity1 @entity55 @entity5 @entity254 @entity189 @entity260 @entity6783 @entity418 @entity1282 @entity912
Surgery for @entity189 and @entity418 represents potentially curative therapy in early stage of @entity5 . In the advanced stage of @entity5 palliation is the only remaining therapeutic aim. In a retrospective study covering the period 1984-1992 we analyzed 51 @entity1 who underwent surgery for esophageal or @entity5 to determine whether palliation by surgery is feasible. We also analyzed morbidity and mortality of peri- and @entity260 . In 88% we carried out standard esophagectomy consisting of abdomino-thoracic access, gastric interposition with thoracic @entity254 and extramucous pyloromyotomy. In the light of postresection histology, 53% of the operations were potentially curative (UICC stage I and II) [1], 47% palliative (UICC stage III and IV) [1]. Perioperative 30-days mortality was nil, perioperative 30-days morbidity 11% (3 @entity1 developed @entity55 postoperatively, 2 @entity1 with cervical @entity254 developed @entity6783 of @entity254 which in both cases healed completely with conservative therapy, while a further @entity1 with cervical @entity254 suffered persistent @entity912 of the recurrent nerve. All @entity1 were fully able to feed themselves at the time of discharge. 43% of @entity1 had recurrent @entity1282 and 24% underwent endoscopic dilatation. Three-year survival was 26%. From these results it may be concluded that esophageal resection represents either good palliation with low morbidity for the majority of @entity1 with non-resectable @entity189 or potentially curative therapy with low morbidity in early stage of @entity5 .
